A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors - Hänse, Nicole; Marmé, Frederik (BioMed Central; Springer, 2016)
Aus: BMC Cancer, 16 (2016), Nr. 420. pp. 1-10. ISSN 1471-2407